AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...
January 17, 2025--DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with ... rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]) showed ...
THE WEEK’S MOST POPULAR SONGS RANKED BY ADULT CONTEMPORARY RADIO AIRPLAY DETECTIONS, AS MEASURED BY MEDIABASE AND PROVIDED BY LUMINATE. Teddy Swims Last week Weeks at no. 1 Weeks on chart J.E ...
The headline result from the MATINEE trial of IL-5 inhibitor Nucala (mepolizumab) in adults with COPD was ... include chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with ...
Specifically, the FDA approved Omvoh to treat moderately to severely active Crohn's disease in adults. In a phase ... chronic rhinosinusitis with nasal polyps (CRSwNP), a condition that impacts ...
The first to unmask all of its opponents’ spies wins. “This is my favorite party game when mixing kids and adults,” says Scott Cooper, owner of Seattle-based Blue Highway Games. A cross ...
Use of SGLT2 inhibitors was associated with improved kidney health among a diverse multiethnic cohort of Asian adults with type 2 diabetes, researchers found in a retrospective cohort study.
1 Cancer Research UK Colorectal Cancer Unit, St Mark’s Hospital, Harrow, Middlesex HA1 3UJ, UK 2 Wolfson Unit for Endoscopy, St Mark’s Hospital Most colon cancers are assumed to have a premalignant ...